Aileron Therapeutics, Inc.
ALRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13 | $17 | $5 | $4 |
| Short-Term Investments | $0 | $0 | $16 | $42 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $2 |
| Total Curr. Assets | $14 | $18 | $22 | $48 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $6 | $6 | $0 | $0 |
| Intangibles | $42 | $79 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $2 | $0 | $0 |
| Total NC Assets | $49 | $88 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $62 | $106 | $22 | $48 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $3 | $2 | $3 |
| Total Curr. Liab. | $6 | $4 | $3 | $5 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $3 | $0 | $0 |
| Other NC Liab. | $0 | $91 | $0 | $0 |
| Total NC Liab. | $2 | $95 | $2 | $0 |
| Other Liabilities | $0 | $0 | -$2 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $8 | $99 | $3 | $5 |
| Equity | – | – | – | – |
| Pref Stock | $45 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$351 | -$289 | -$273 | -$245 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $406 | $204 | $291 | $289 |
| Total Equity | $54 | $7 | $19 | $44 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $62 | $106 | $22 | $48 |
| Net Debt | -$13 | -$17 | -$5 | -$3 |